June 4 (Reuters) - US Oncology Inc on Thursday sold $775
million of eight-year senior secured second lien notes in the
144a private placement market, said IFR, a Thomson Reuters
service.

The size of the deal was increased from an originally
planned $465 million.

Morgan Stanley, Deutsche Bank, JP Morgan, and Wachovia
were the joint bookrunning managers for the sale.
BORROWER: US ONCOLOGY INC
AMT $775 MLN* COUPON 9.125 PCT MATURITY 8/15/2017
TYPE SR SEC NTS ISS PRICE 97.926 FIRST PAY 8/15/2009
MOODY'S Ba3 YIELD 9.500 PCT SETTLEMENT 6/18/2009
S&P SINGLE-B SPREAD 606 BPS PAY FREQ SEMI-ANNUAL
FITCH N/A MORE THAN TREAS MAKE-WHOLE CALL 50 BPS
*$758.9265 MLN PROCEEDS TO ISSUER